Moreover, the percentage of patients who changed from warfarin to DOACs differed between the groups with a decreasing trend toward highly sensitive responders (6.8%, 4.6% and 1.3%).
← all excerpts
Pharmacogenetics of Anticoagulation and Clinical Events in Warfarin-Treated Patients: A Register-Based Cohort Study with Biobank Data and National Health Registries in Finland.
1
—
—